Recent Finacing
Recent Raise
Corner Therapeutics develops antigen-agnostic immune therapies and vaccines that program durable, disease-specific T cells for oncology and infectious-disease targets including HIV, influenza, and COVID-19.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Corner Therapeutics.
